Roche completes acquisition of TIB Molbiol

Roche completed the acquisition of 100% of TIB Molbiol Group, a developer of PCR assays for emerging infectious diseases. TIB Molbiol will operate as a subsidiary within Roche Diagnostics.

“Roche today announced it has completed its share purchase agreement to acquire 100 percent of the outstanding shares of TIB Molbiol Group.”roche.com

• 1 source
• roche.comRoche completes purchase agreement with long-term partner TIB Molbiol to expand PCR-test portfolio in the fight against new infectious diseasesDec 1, 2021

Summarized from public sources; check the original articles before acting on it.